| 000 | 01763 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517041447.0 | ||
| 264 | 0 | _c20160523 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1399-0020 | ||
| 024 | 7 |
_a10.1016/j.ijom.2015.06.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCosta, F W G | |
| 245 | 0 | 0 |
_aA split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars. _h[electronic resource] |
| 260 |
_bInternational journal of oral and maxillofacial surgery _cSep 2015 |
||
| 300 |
_a1166-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEtoricoxib |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMandible _xsurgery |
| 650 | 0 | 4 |
_aMolar, Third _xsurgery |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aPain, Postoperative _xprevention & control |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfones _xtherapeutic use |
| 650 | 0 | 4 | _aTooth Extraction |
| 650 | 0 | 4 |
_aTooth, Impacted _xsurgery |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSoares, E C S | |
| 700 | 1 | _aEsses, D F S | |
| 700 | 1 | _aSilva, P G deB | |
| 700 | 1 | _aBezerra, T P | |
| 700 | 1 | _aScarparo, H C | |
| 700 | 1 | _aRibeiro, T R | |
| 700 | 1 | _aFonteles, C S R | |
| 773 | 0 |
_tInternational journal of oral and maxillofacial surgery _gvol. 44 _gno. 9 _gp. 1166-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijom.2015.06.012 _zAvailable from publisher's website |
| 999 |
_c25046167 _d25046167 |
||